Gut bacteria, collectively referred to as the gut microbiota, form a complex and diverse community of microorganisms inhabiting the gastrointestinal tract. Comprising bacteria, viruses, fungi, and other microbes, this ecosystem plays a fundamental role in maintaining overall health. The gut microbiota aids in digestion, nutrient absorption, and the synthesis of certain vitamins. Beyond digestive functions, gut bacteria actively contribute to the immune system's development and regulation, influencing immune responses throughout the body. They produce metabolites, such as short-chain fatty acids, that impact host physiology and play a role in metabolic processes. The composition of gut bacteria is influenced by various factors, including diet, lifestyle, and genetics. A balanced and diverse microbiota is associated with better health outcomes, while disruptions (dysbiosis) may contribute to various disorders, including gastrointestinal issues, metabolic conditions, and immune-related diseases. Research continues to uncover the intricate interactions between gut bacteria and various aspects of health, leading to insights into potential therapeutic interventions. Probiotics, prebiotics, and dietary strategies are explored to modulate and support the gut microbiota, emphasizing the significance of this microbial community in maintaining a harmonious balance within the body.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States